Your browser doesn't support javascript.
loading
Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the National Cancer Database.
MacLean, Matthew; Luo, Xin; Wang, Shidan; Kernstine, Kemp; Gerber, David E; Xie, Yang.
Afiliación
  • MacLean M; Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.
  • Luo X; Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Wang S; Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.
  • Kernstine K; Department of Cardio Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Gerber DE; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Xie Y; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Oncotarget ; 9(36): 24470-24479, 2018 May 11.
Article en En | MEDLINE | ID: mdl-29849954
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article